Institutional Ownership
Alnylam Pharmaceuticals Inc
CUSIP 02043QAB3NOTE 1.000% 9/1ALNYQ1 2026
Insider Transactions
303
Form 4 lines on record
Reporting Insiders
17
Distinct officers & directors
90d Buys
0
Open-market purchase shares
90d Sells
3.8K
Open-market sale shares
Insider Transactions — Form 4
303 reported transactions
| # | Date | Insider | Title | Type | Shares | Price | Value | Held After | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Jun 1, 2026 | Pyott David E I | Director | M · Option Exercise | 3.8K | — | — | 5.4K | SEC |
| 2 | Jun 1, 2026 | Pyott David E I | Director | S · Sell | 921 | $297.71 | $274.2K | 4.5K | SEC |
| 3 | Jun 1, 2026 | Pyott David E I | Director | S · Sell | 1.2K | $298.91 | $351.2K | 3.3K | SEC |
| 4 | Jun 1, 2026 | Pyott David E I | Director | S · Sell | 1.2K | $299.87 | $366.4K | 2.1K | SEC |
| 5 | Jun 1, 2026 | Pyott David E I | Director | S · Sell | 495 | $300.72 | $148.9K | 1.6K | SEC |
| 6 | Jun 1, 2026 | Pyott David E I | Director | S · Sell | 17 | $302.65 | $5.1K | 1.6K | SEC |
| 7 | Jun 1, 2026 | Pyott David E I | Director | M · Option Exercise | 3.8K | — | — | 0 | SEC |
| 8 | Jun 1, 2026 | Cravatt Benjamin | Director | A · Grant | 4.4K | — | — | 4.4K | SEC |
| 9 | May 20, 2026 | Sigal Charles Elliott | Director | A · Grant | 671 | — | — | 1.4K | SEC |
| 10 | May 20, 2026 | Sigal Charles Elliott | Director | A · Grant | 1.4K | — | — | 1.4K | SEC |
293 more insider transactions on Premium
See the full Form 4 transaction history for Alnylam Pharmaceuticals Inc.
Unlock all transactions